BMJ Best Practice

参考文献

关键文献

Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.

Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3:389-400.

参考文章

1.  Sladden MJ, Johnston GA. Current options for the treatment of impetigo in children. Expert Opin Pharmacother. 2005;6:2245-2256.

2.  George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract. 2003;53:480-487.

3.  Sladden MJ, Johnston GA. Common skin infections in children. BMJ. 2004;329:95-99.

4.  Edlich RF, Winters KL, Britt LD, et al. Bacterial diseases of the skin. J Long Term Eff Med Implants. 2005;15:499-510.

5.  Yu Y, Cheng AS, Wang L, et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol. 2007;57:596-600.

6.  Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician. 2002;66:119-124.

7.  Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5:301-310.

8.  Boni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003;4:273-276.

9.  Dylewski J, Duong M. The rash of secondary syphilis. CMAJ. 2007;176:33-35.

10.  Miller AC, Rashid RM, Khachemoune A. Secondary syphilis. J Emerg Med. 2008;35:83-85.

11.  Centers for Disease Control and Prevention. Syphilis. September 2017 [internet publication].

12.  Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis. 2002;185:1019-1024.

13.  Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26:397-411.

14.  Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-121.

15.  Swick BL, DeBates SM. A solitary nodule on the finger. Arch Dermatol. 2009;145:321-326.

16.  Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.

17.  Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42:244-251.

18.  Spellberg B. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog. 2008;4:e38.

19.  Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34:857-863.

20.  Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67:101-108.

21.  Karthikeyan K. Scabies in children. Arch Dis Child Educ Pract Ed. 2007;92:65-69.

22.  Shahzad N, Nasir J, Ikram U, et al. Frequency and psychosocial impact of acne on university and college students. J Coll Physicians Surg Pak. 2011;21:442-443.

23.  Clarke SB, Nelson AM, George RE, et al. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications. Dermatol Clin. 2007;25:137-146, v.

24.  Webster GF. Pustular drug reactions. Clin Dermatol. 1993;11:541-543.

25.  Fraser SJ, Benton EC, Roddie PH, et al. Eosinophilic folliculitis: an important differential diagnosis after allogeneic bone-marrow transplant. Clin Exp Dermatol. 2009;34:369-371.

26.  Nervi SJ, Schwartz RA, Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol. 2006;55:285-289.

27.  Lankerani L, Thompson R. Eosinophilic pustular folliculitis: case report and review of the literature. Cutis. 2010;86:190-194.

28.  Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555-560.

29.  El Menyawi MM, Raslan HM, Edrees A. Clinical features of Behcet's disease in Egypt. Rheumatol Int. 2009;29:641-646.

30.  Alexander AM, Delph WI. Pseudofolliculitis barbae in the military. A medical, administrative and social problem. J Natl Med Assoc. 1974;66:459-479.

31.  Edlich RF, Haines PC, Nichter LS, et al. Pseudofolliculitis barbae with keloids. J Emerg Med. 1986;4:283-286.

32.  Perry PK, Cook-Bolden FE, Rahman Z, et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46:113-119.

33.  Ratnarathorn M, Newman J. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) occurring in association with nodal marginal zone lymphoma: a case report. Dermatol Online J. 2008;14:6.

34.  Good LM, Good TJ, High WA. Infantile acropustulosis in internationally adopted children. J Am Acad Dermatol. 2011;65:763-771.

35.  Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol. 1998;15:337-341.

36.  Marchini G, Nelson A, Edner J, et al. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant. Pediatr Res. 2005;58:613-616.

37.  Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3:389-400.

38.  deShazo RD, Williams DF, Moak ES. Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med. 1999;131:424-429.

39.  Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol. 2007;57:1012-1018.

40.  Conlon JD, Drolet BA. Skin lesions in the neonate. Pediatr Clin North Am. 2004;51:863-388, vii-viii.

41.  Feng E, Janniger CK. Miliaria. Cutis. 1995;55:213-216.

42.  Kirk JF, Wilson BB, Chun W, et al. Miliaria profunda. J Am Acad Dermatol. 1996;35:854-856.

43.  Oltz M, Check J. Rosacea and its ocular manifestations. Optometry. 2011;82:92-103.

44.  Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450.

45.  Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007 Aug;13(8):975-80.

46.  Wu IB, Schwartz RA. Reiter's syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59:113-121.

47.  Brill TJ, Elshorst-Schmidt T, Valesky EM, et al. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Dermatology. 2005;211:351-355.

48.  Dirschka T. Periorale dermatitis. Bochum: Ruhr-Universität; 2004.

49.  Rodriguez-Martin M, Saez-Rodriguez M, Carnerero-Rodriguez A, et al. Treatment of perioral dermatitis with topical pimecrolimus. J Am Acad Dermatol. 2007;56:529-530.

50.  Kerl K, Masouyé I, Lesavre P, et al. A case of amicrobial pustulosis of the folds associated with neutrophilic gastrointestinal involvement in systemic lupus erythematosus. Dermatology. 2005;211:356-359.

51.  Lee HY, Pelivani N, Beltraminelli H, et al. Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker. Dermatology. 2011;222:304-310.

52.  Agero AL, Dusza SW, Benvenuto-Andrade C, et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006;55:657-670.

53.  Van Doorn R, Kirtschig G, Scheffer E, et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol. 2002;147:598-601.

54.  Röckl H. Leukocytoclastic vasculitis due to drug allergy presenting as generalized pustular exanthema [in German]. Hautarzt. 1981;32:467-470.

55.  Roujeau IC, Bioulac-Sage P, Boursean C, et al. Acute generalised exanthematous pustulosis: analysis of 63 cases. Arch Dermatol. 1991;127:1333-1338.

56.  Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.

57.  Maoz KB, Brenner S. Drug rash with eosinophilia and systemic symptoms syndrome: sex and the causative agent. Skinmed. 2007;6:271-273.

58.  Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol. 2007;21:484-490.

59.  Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295:43-54.

60.  Iizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res. 2003;295:55-59.

61.  Serra D, Gonçalo M, Mariano A, et al. Pustular psoriasis and drug-induced pustulosis. G Ital Dermatol Venereol. 2011;146:155-158.

62.  Ozawa A, Miyahara M, Sugai J, et al. HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303. J Dermatol. 1998;25:573-581.

63.  Larsen CG, Thyssen JP. Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment. Acta Derm Venereol. 2012;92:104-105.

64.  Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37-46.

65.  Nanda S, Reddy BS, Ramji S, et al. Analytical study of pustular eruptions in neonates. Pediatr Dermatol. 2002;19:210-215.

66.  Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120:627-632.

67.  Eleftheriou LI, McIntee TJ, Stratman EJ. Aminolevulinic acid photodynamic therapy in the treatment of erosive pustular dermatosis of the scalp. Arch Dermatol. 2011;147:1368-1370.

68.  Odom RB, James WD, Berger TG. Andrew's disease of the skin: clinical dermatology. 9th ed. Philadelphia, PA: W.B. Saunders Company; 2000.

69.  Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. London: Mosby; 2007.

70.  Coquilla BH, Lewis CW. Management of pseudofolliculitis barbae. Mil Med. 1995;160:263-269.

71.  Quarles FN, Brody H, Johnson BA, et al. Pseudofolliculitis barbae. Dermatol Ther. 2007;20:133-136.

72.  Van Praag MC, Van Rooij RW, Folkers E, et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol. 1997;14:131-143.

73.  Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12:204.

74.  Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol. 2001;28:113-119.

75.  Tamir E, Wohl Y, Mashiah J, et al. Acute generalized exanthematous pustulosis: a retrospective analysis showing a clear predilection for women. Skinmed. 2006;5:186-188.

76.  Fung MA, Berger TG. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids. Dermatology. 2000;200:43-44.

77.  Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Microbiol Rev. 2005;18:205-216.

78.  Smolinski KN, Shah SS, Honig PJ, et al. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005;17:486-493.

79.  López-Navarro N, Alcaide A, Gallego E, et al. Amicrobial pustulosis of the folds associated with Hashimoto's thyroiditis. Clin Exp Dermatol. 2009;34:e561-e563.

80.  Alves EV, Martins JE, Ribeiro EB, et al. Pityrosporum folliculitis: renal transplantation case report. J Dermatol. 2000;27:49-51.

81.  Schwarz T, Kreiselmaier I, Bieber T, et al. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008;59:34-40.

82.  Boer A, Herder N, Winter K, et al. Herpes folliculitis: clinical, histopathological, and molecular pathologic observations. Br J Dermatol. 2006;154:743-746.

83.  Weinberg JM, Mysliwiec A, Turiansky GW, et al. Viral folliculitis. Atypical presentation of herpes simplex, herpes zoster and molluscum contagiosum. Arch Dermatol. 1997;133:983-986.

84.  Nakamura K, Imakado S, Takizawa M, et al. Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. J Am Acad Dermatol. 2000;42:1021-1025.

85.  Poli F, Prost C, Revuz J. Gram-negative bacteria folliculitis [in French]. Ann Dermatol Venereol. 1988;115:797-800.

86.  Khera P, Haught JM, McSorley J, et al. Atypical presentations of herpesvirus infections in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2009;60:484-486.

87.  Bundino S, Zina AM, Ubertalli S. Infantile acropustulosis. Dermatologica. 1982;165:615-619.

88.  Sotiriadis D, Patsatsi A, Sotiriou E, et al. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate. J Dermatolog Treat. 2007;18:315-318.

89.  Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J. 2007;48:573-585.

90.  Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.

91.  Halevy S, Cohen A, Livni E. Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon-gamma release test. Clin Exp Dermatol. 2000;25:652-654.

使用此内容应接受我们的免责声明